Mar 03, 2020 / 09:35PM GMT
John Wilson Ransom - Raymond James & Associates, Inc., Research Division - MD of Equity Research & Director of Healthcare Research
Good afternoon, everyone. We're in the home stretch of the Tuesday of the 41st Annual Raymond James Conference. Thanks for hanging in, everybody. We've got the -- it's been an interesting year. I think the -- after a management regime change about a year ago, it feels like things are a little bit of planning. And now we're kind of into more information and execution. So we think the story is starting to get interesting. I would say the company's earnings report last week, the feedback would have been that the headline numbers were in line, but probably tilted a little more towards the U.K. than the U.S. and kind of good news/bad news.
If you're selling in the U.K., you get a better price for that EBITDA. But I think probably the U.S. numbers were just a little bit behind what people were thinking. But we think after kind of a sideways period, it looks like the earnings growth should start to pick up back half of this year into next year. And the stock's trading
Acadia Healthcare Company Inc at Raymond James Institutional Investors Conference Transcript
Feb 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers